This week was for introductions:
- At the Cross-Border Biotech Blog, we introduced a new science writer! Richard Chan started off with his first Friday Science Review and he covered a lot of ground, from obesity to toucans to sushi.
- Direct-to-consumer genetic testing was introduced to Canada this week and we’ll continue to follow the trend worldwide, all the way to Gattaca if neccesary.
- The Globe and Mail introduced its readers to Canada’s longest-running biotech takeover battle, the JLL-Patheon bid, which has been constant fodder for the blog’s Monday Deal Review since January.
- The Ministry of Research and Innovation launched the $250 million Emerging Technologies Fund, which will co-invest up to $50 million a year over the next 5 years in Ontario companies.
This coming week is a short one, but stay tuned to the Cross-Border Biotech Blog for all things Canadian and biotech-y and good. Also check out the tweeting @crossborderbio.